Gene Therapy is a promising field in biotechnology aimed at treating genetic disorders by introducing therapeutic genes into a patient's cells. This cutting-edge approach holds the potential to revolutionize medicine by addressing the root causes of diseases at the genetic level. One of the key strategies in gene therapy involves the use of viral vectors to deliver therapeutic genes into target cells. These vectors are modified viruses that are rendered harmless but retain their ability to infect cells and deliver genetic material. Once inside the cell, the therapeutic gene can either replace a defective gene or supplement its function, restoring normal cellular activity. However, challenges such as immune responses to the viral vectors and the risk of unintended genetic changes must be carefully addressed. Gene therapy has shown remarkable success in treating certain genetic disorders, such as severe combined immunodeficiency (SCID), hemophilia, and certain types of inherited blindness. Ongoing research aims to expand the application of gene therapy to a broader range of diseases, including cancer, neurodegenerative disorders, and cardiovascular diseases. The development of more precise gene editing techniques, such as CRISPR-Cas9, holds great promise for enhancing the effectiveness and safety of gene therapy. Despite the immense potential, gene therapy still faces regulatory hurdles and ethical considerations, particularly regarding the long-term effects and accessibility of treatment. Nevertheless, ongoing advancements in gene therapy continue to drive progress towards safer, more effective treatments for a wide range of genetic diseases, offering hope for patients and clinicians alike.
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico